Adjuvant Chemotherapy in Older Women With Breast Cancer: Who and What?
Author:
Affiliation:
1. University of North Carolina, Chapel Hill, NC
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.54.8586
Reference42 articles.
1. Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?
2. Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies
3. Cancer Screening in Elderly Patients
4. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial;European Journal of Cancer;2023-11
2. Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ;Frontiers in Surgery;2023-05-05
3. Emerging potentials of nanotherapeutics in breast cancer microenvironment targeting;OpenNano;2022-11
4. Potential of Anti-inflammatory Molecules in the Chemoprevention of Breast Cancer;Recent Advances in Inflammation & Allergy Drug Discovery;2022-09
5. Evaluation of whether adjuvant chemotherapy can be safely omitted for older female patients with ER-positive, HER2-negative N1 breast cancer: a study based on the SEER database;Annals of Translational Medicine;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3